Achillion Company Profile

13:38 EDT 18th March 2018 | BioPortfolio

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The Company’s discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease — HIV, hepatitis and resistant bacterial infections. Achillion’s drug development pipeline is led by elvucitabine (Beta-L-Fd4C or ACH-126,443), which is currently in late-stage Phase 2 clinical trials for the treatment of patients infected with HIV. Achillion’s candidate for the potential treatment of HCV infection, ACH-806, is in a Phase 1 clinical trial and is anticipated to be completed by the first half of 2006.


300 George Street
New Haven,
United States of America


Phone: 203-624-7000
Fax: 203-624-7003

News Articles [57 Associated News Articles listed on BioPortfolio]

USPTO Grants Composition of Matter Patent to Achillion for ACH-4471,...

Achillion Pharmaceuticals, Inc. today announced that the U.S. Patent and Trademark Office has issued a U.S. Patent to Achillion for ACH-4471. U.S. Patent No.

-$0.15 EPS Expected for Achillion Pharmaceuticals, Inc. (ACHN) This Quarter

Equities analysts expect that Achillion Pharmaceuticals, Inc. will post earnings of per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Achillio...

J&J exits Achillion, Achillion pockets $50.5M

Zacks: Brokerages Expect Achillion Pharmaceuticals, Inc. (ACHN) to Post -$0.18 EPS

Brokerages forecast that Achillion Pharmaceuticals, Inc. will post earnings per share for the current quarter, according to Zacks . Zero analysts have made estimates for Achillion Pharmaceuticals'...

Achillion Slashes Staff and Initiates Restructuring Following Termination of J&J Deal

Achillion is handing out pink slips to 20 percent of its employees and initiating an operational restructuring plan.

Achillion Pharmaceuticals (ACHN) & Selecta Biosciences (SELB) Critical Comparison

Achillion Pharmaceuticals and Selecta Biosciences are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earning...

Achillion Pharmaceuticals (ACHN) - Termination of coverage

Edison Investment Research - Pharmaceutical & healthcare - Achillion Pharmaceuticals: Edison Investment Research is terminating coverage on Achillion Pharmaceuticals (ACHN). Please note you should no ...

Achillion Pharmaceuticals (ACHN) Sets New 12-Month Low at $2.91

Achillion Pharmaceuticals, Inc. 's share price hit a new 52-week low during trading on Thursday . The stock traded as low as $2.91 and last traded at $2.99, with a volume of 1250800 shares changin...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.

The purpose of this study is to determine the safety and antiviral HBV activity of ACH-126,443 (beta-L-Fd4C) in the treatment of Subjects of Previous Achillion-Sponsored Phase 1 and 2 Stud...

Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation

HIV-1 infected patients receiving long-term therapy with lamivudine or emtricitabine (nucleoside reverse transcriptase inhibitors [NRTIs]) are at risk for the development of a mutation at ...

Companies [2 Associated Companies listed on BioPortfolio]


Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The Company’s discovery and development teams have advanced mult...

Achillion Pharmaceuticals

Achillion is a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative small molecule drugs that combat drug resistance in infectious diseases, ...

More Information about "Achillion" on BioPortfolio

We have published hundreds of Achillion news stories on BioPortfolio along with dozens of Achillion Clinical Trials and PubMed Articles about Achillion for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Achillion Companies in our database. You can also find out about relevant Achillion Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record